Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Omega-3 fatty acids for bipolar disorder
Your Article Summary
See Latest ArticlesPharmacotherapy for Cannabis Dependence: How Close Are We
CNS Drugs, 06/29/09
Vandrey R et al. - Results from controlled laboratory studies and small open-label clinical studies indicate that buspirone, dronabinol, fluoxetine, lithium and lofexidine may have therapeutic benefit for those seeking treatment for cannabis-related problems. However, controlled clinical trials have not been conducted and are needed to both confirm the potential clinical efficacy of these medications and to validate the laboratory models being used to study candidate medications.
Related Articles
New UK study suggests minimal relationship between cannabis and schizophrenia or psychosis
EurekAlert, 10/23/09
Relevance Score: 91%
If cannabis caused schizophrenia how many cannabis users may need to be prevented in order to prevent one case of schizophrenia? England and Wales calculations
Addiction, 10/19/09
Relevance Score: 91%
Adverse health effects of non-medical cannabis use
The Lancet, 10/19/09
Relevance Score: 88%
Cannabis and First-Episode Psychosis: Different Long-term Outcomes Depending on Continued or Discontinued Use
Schizophrenia Bulletin, 11/16/09
Relevance Score: 87%
Intrauterine Cannabis Exposure Affects Fetal Growth Trajectories: The Generation R Study
Journal of the American Academy of Child and Adolescent Psychiatry, 10/29/09
Relevance Score: 87%
Today in Neuro/Psych Pharmacol...keeping you current
Receive free subspecialty "5-minute updates" via email
Zuclopenthixol-induced neuroleptic malignant syndrome presenting as fever of unknown origin, hyperglycaemia and acute myocardial infarction in a 60-year-old man
World Journal of Biological Psychiatry, 12/19/09
Quetiapine-associated dysphagia
World Journal of Biological Psychiatry, 12/19/09
A case with occurring adverse effects when cross-over titration from fluvoxamine to paroxetine associated with increasing the plasma fluvoxamine level in major depressive disorder
World Journal of Biological Psychiatry, 12/19/09
Today in Neuro/Psych Pharmacol...keeping you current
Receive free subspecialty "5-minute updates" via email
Zuclopenthixol-induced neuroleptic malignant syndrome presenting as fever of unknown origin, hyperglycaemia and acute myocardial infarction in a 60-year-old man
World Journal of Biological Psychiatry, 12/19/09
Quetiapine-associated dysphagia
World Journal of Biological Psychiatry, 12/19/09
A case with occurring adverse effects when cross-over titration from fluvoxamine to paroxetine associated with increasing the plasma fluvoxamine level in major depressive disorder
World Journal of Biological Psychiatry, 12/19/09
Today in Substance Abuse...keeping you current
Receive free subspecialty "5-minute updates" via email
Impact of Substance Use Disorders on Recovery From Episodes of Depression in Bipolar Disorder Patients: Prospective Data From the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)
American Journal of Psychiatry, 12/19/09
D-Cycloserine and Cocaine Cue Reactivity: Preliminary Findings
American Journal of Drug & Alcohol Abuse, 12/19/09
Characteristics of Opioid-Using Pregnant Women Who Accept or Refuse Participation in a Clinical Trial: Screening Results from the MOTHER Study
American Journal of Drug & Alcohol Abuse, 12/19/09
Sponsor
Article Search
Sponsor
Sponsor